NCT07010471 - A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

July 9, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions

Developmental and Epileptic Encephalopathy 1

Interventions

DRUG

1.0mg/kg/day PRAX-562

Once daily orally or gastronomy/jejunostomy

DRUG

1.5mg/kg/day PRAX-562

Once daily orally or gastronomy/jejunostomy

DRUG

Placebo

Once daily orally or gastronomy/jejunostomy

Trial Locations (1)

RECRUITING

Praxis Research Site, Chevy Chase